제약 CSO(Pharmaceutical Contract Sales Organization) 시장 규모, 점유율, 동향 분석 보고서 : 서비스별, 치료 분야별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Pharmaceutical Contract Sales Organizations Market Summary

The global pharmaceutical contract sales organizations market size was valued at USD 11.9 billion in 2025 and is projected to grow from USD 12.9 billion in 2026 to USD 23.8 billion by 2033, at a CAGR of 9.1% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 37.9% in 2025. The market growth is driven by the increasing number of new drug launches, a rise in pharmaceutical R&D activities, growing demand to reduce costs associated with in-house sales, rising complexity of drug commercialization, increasing regulatory oversight, and the ongoing need for cost optimization.

Global Pharmaceutical Contract Sales Organizations Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmaceutical contract sales organizations market report based on service, therapeutic area, end use, and region.

• Service Outlook (Revenue, USD Billion, 2021 - 2033)
• Personal Promotion
  • Promotional sales team
  • Key account management
  • Vacancy Management
• Non-personal promotion
  • Medical affairs solutions
  • Remote medical science liaisons
  • Nurse educators
  • Others
• Therapeutic Area Outlook (Revenue, USD Billion, 2021 - 2033)
• Oncology
• Cardiovascular
• Neurology
• Infectious Diseases
• Metabolic Disorders
• Orthopedic Diseases
• Others
• End Use Outlook (Revenue, USD Billion, 2021 - 2033)
• Pharmaceutical Companies
• Biopharmaceutical Companies
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Oman
  • Qatar

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Service
  • 1.2.2. Therapeutic Area
  • 1.2.3. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Top-Down Analysis
  • 1.7.3. Bottom-up Approach
  • 1.7.4. Multivariate Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Pharmaceutical Contract Sales Organizations Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Technology Landscape
• 3.4. Pricing Model Analysis
• 3.5. Tariff Impact Analysis
• 3.6. Value Chain Analysis
  • 3.6.1. Supply Trends
  • 3.6.2. Demand Trends
• 3.7. Market Analysis Tools
  • 3.7.1. Porter's Five Forces Analysis
  • 3.7.2. PESTEL Analysis

Chapter 4. Pharmaceutical Contract Sales Organizations Market: Service Estimates & Trend Analysis

• 4.1. Pharmaceutical Contract Sales Organizations Market, By Service: Segment Dashboard
• 4.2. Pharmaceutical Contract Sales Organizations Market, By Service: Movement Analysis
• 4.3. Pharmaceutical Contract Sales Organizations Market Estimates & Forecasts, By Service, 2021 - 2033
• 4.4. Personal Promotion
  • 4.4.1. Personal Promotion Market Estimates and Forecasts 2021 to 2033 (USD Billion)
  • 4.4.2. Promotional Sales Team
    • 4.4.2.1. Promotional Sales Team Market Estimates and Forecasts 2021 to 2033 (USD Billion)
  • 4.4.3. Key Account Management
    • 4.4.3.1. Key Account Management Market Estimates and Forecasts 2021 to 2033 (USD Billion)
  • 4.4.4. Vacancy Management
    • 4.4.4.1. Vacancy Management Market Estimates and Forecasts 2021 to 2033 (USD Billion)
• 4.5. Non-personal Promotion
  • 4.5.1. Non-personal Promotion Market Estimates and Forecasts 2021 to 2033 (USD Billion)
  • 4.5.2. Medical Affairs Solutions
    • 4.5.2.1. Medical Affairs Solutions Market Estimates and Forecasts 2021 to 2033 (USD Billion)
  • 4.5.3. Remote Medical Science Liaisons
    • 4.5.3.1. Remote Medical Science Liaisons Market Estimates and Forecasts 2021 to 2033 (USD Billion)
  • 4.5.4. Nurse Educators
    • 4.5.4.1. Nurse Educators Market Estimates and Forecasts 2021 to 2033 (USD Billion)
  • 4.5.5. Others
    • 4.5.5.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Billion)

Chapter 5. Pharmaceutical Contract Sales Organizations Market: Therapeutic Area Estimates & Trend Analysis

• 5.1. Pharmaceutical Contract Sales Organizations Market, By Therapeutic Area: Segment Dashboard
• 5.2. Pharmaceutical Contract Sales Organizations Market, By Therapeutic Area: Movement Analysis
• 5.3. Pharmaceutical Contract Sales Organizations Market Estimates & Forecasts, By Therapeutic Area, 2021 - 2033
• 5.4. Oncology
  • 5.4.1. Oncology Market Estimates and Forecasts 2021 to 2033 (USD Billion)
• 5.5. Cardiovascular
  • 5.5.1. Cardiovascular Market Estimates and Forecasts 2021 to 2033 (USD Billion)
• 5.6. Neurology
  • 5.6.1. Neurology Market Estimates and Forecasts 2021 to 2033 (USD Billion)
• 5.7. Infectious Diseases
  • 5.7.1. Infectious Diseases Market Estimates and Forecasts 2021 to 2033 (USD Billion)
• 5.8. Metabolic Disorders
  • 5.8.1. Metabolic Disorders Market Estimates and Forecasts 2021 to 2033 (USD Billion)
• 5.9. Orthopedic Diseases
  • 5.9.1. Orthopedic Diseases Market Estimates and Forecasts 2021 to 2033 (USD Billion)
• 5.10. Others
  • 5.10.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Billion)

Chapter 6. Pharmaceutical Contract Sales Organizations Market: End Use Estimates & Trend Analysis

• 6.1. Pharmaceutical Contract Sales Organizations Market, By End Use: Segment Dashboard
• 6.2. Pharmaceutical Contract Sales Organizations Market, By End Use: Movement Analysis
• 6.3. Pharmaceutical Contract Sales Organizations Market Estimates & Forecasts, By End Use, 2021 - 2033
• 6.4. Pharmaceutical Companies
  • 6.4.1. Pharmaceutical Companies Market Estimates and Forecasts 2021 to 2033 (USD Billion)
• 6.5. Biopharmaceutical Companies
  • 6.5.1. Biopharmaceutical Companies Market Estimates and Forecasts 2021 to 2033 (USD Billion)

Chapter 7. Pharmaceutical Contract Sales Organizations Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Dashboard
• 7.2. Regional Market Share Analysis, 2025 & 2033
• 7.3. North America
  • 7.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.3.2. U.S
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Framework
    • 7.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 7.4. Europe
  • 7.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Framework
    • 7.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Framework
    • 7.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Regulatory Framework
    • 7.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.5.5. Thailand
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.5.6. South Korea
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.5.7. Australia
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 7.6. Latin America
  • 7.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 7.7. MEA
  • 7.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.7.6. Oman
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Competitive Scenario
    • 7.7.6.3. Regulatory Framework
    • 7.7.6.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.7.7. Qatar
    • 7.7.7.1. Key Country Dynamics
    • 7.7.7.2. Competitive Scenario
    • 7.7.7.3. Regulatory Framework
    • 7.7.7.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Key Participant Categorization
  • 8.1.1. Market Leaders
  • 8.1.2. Emerging Players
• 8.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
• 8.3. Company Profiles
  • 8.3.1. CMIC Holdings Co., Ltd.
    • 8.3.1.1. Company Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Service Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Axxelus
    • 8.3.2.1. Company Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Service Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. EPS Corp.
    • 8.3.3.1. Company Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Service Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. QFR Solutions
    • 8.3.4.1. Company Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Service Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. MaBico
    • 8.3.5.1. Company Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Service Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Mednext Pharma Pvt. Ltd.
    • 8.3.6.1. Company Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Service Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. Peak Pharma Solutions Inc.
    • 8.3.7.1. Company Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Service Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. IQVIA, Inc.
    • 8.3.8.1. Company Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Service Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Promoveo Health
    • 8.3.9.1. Company Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Service Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. Syneos Health
    • 8.3.10.1. Company Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Service Benchmarking
    • 8.3.10.4. Strategic Initiatives